GHDXUnknown
GENOMIC HEALTH INC Insider Trading Activity
Every SEC Form 4 insider transaction reported for GENOMIC HEALTH INC (GHDX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are GHDX insiders buying or selling?
GENOMIC HEALTH INC insiders reported no open-market purchases or sales in the last 12 months. Since January 2018, Trabud has recorded 132 Form 4 filings for GHDX: 1 buys ($0) and 131 sells ($456.8M).
Source: SEC EDGAR Form 4
Key Statistics (January 2018 – Nov 13, 2019)
Total Form 4 filings
132
SEC EDGAR
Insider filers
13
Insider buys (1)
$0
Insider sells (131)
$456.8M
Insider sentiment
Net sellingNet insider flow of $456.8M in net selling since January 2018.
Recent GHDX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 13, 2019 | EXACT SCIENCES CORP | Other, 10% Owner | Purchase | 37.6M | $0.00 | $0 | SEC ↗ |
| Oct 21, 2019 | Laura Leber | Chief Communication Officer | Sale | 13.2K | $70.94 | $935.2K | SEC ↗ |
| Oct 9, 2019 | James J Vaughn | Chief Commercial Officer | Sale | 4.5K | $67.75 | $304.9K | SEC ↗ |
| Oct 9, 2019 | Kimberly J Popovits | President and CEO | Sale | 10.0K | $67.74 | $677.4K | SEC ↗ |
| Oct 9, 2019 | Bradley G Cole | CFO | Sale | 22.6K | $69.01 | $1.6M | SEC ↗ |
| Sep 19, 2019 | Steven Shak | Chief Scientific Officer | Sale | 25.0K | $71.47 | $1.8M | SEC ↗ |
| Sep 11, 2019 | Kimberly J Popovits | President and CEO | Sale | 10.0K | $72.53 | $725.3K | SEC ↗ |
| Sep 11, 2019 | Bradley G Cole | CFO | Sale | 43.1K | $72.22 | $3.1M | SEC ↗ |
| Sep 11, 2019 | James J Vaughn | Chief Commercial Officer | Sale | 4.5K | $72.50 | $326.3K | SEC ↗ |
| Aug 21, 2019 | Frederic Pla | COO | Sale | 1.3K | $75.00 | $93.8K | SEC ↗ |
| Aug 19, 2019 | Jason W. Radford | Chief Legal Officer | Sale | 2.2K | $74.13 | $161.7K | SEC ↗ |
| Aug 19, 2019 | Jason W. Radford | Chief Legal Officer | Sale | 3.5K | $83.16 | $291.7K | SEC ↗ |
| Aug 14, 2019 | Bradley G Cole | CFO | Sale | 60.0K | $73.31 | $4.4M | SEC ↗ |
| Aug 14, 2019 | Kimberly J Popovits | President and CEO | Sale | 50.0K | $73.76 | $3.7M | SEC ↗ |
| Aug 12, 2019 | Kimberly J Popovits | President and CEO | Sale | 50.0K | $73.76 | $3.7M | SEC ↗ |
| Aug 12, 2019 | James J Vaughn | Chief Commercial Officer | Sale | 4.5K | $73.74 | $331.8K | SEC ↗ |
| Aug 7, 2019 | Kim Mceachron | Chief People Officer | Sale | 12.1K | $71.53 | $865.7K | SEC ↗ |
| Aug 7, 2019 | Steven Shak | Chief Scientific Officer | Sale | 50.0K | $71.83 | $3.6M | SEC ↗ |
| Aug 5, 2019 | Steven Shak | Chief Scientific Officer | Sale | 50.0K | $72.65 | $3.6M | SEC ↗ |
| Jul 11, 2019 | Bradley G Cole | CFO | Sale | 6.5K | $57.08 | $369.4K | SEC ↗ |
| Jul 10, 2019 | Steven Shak | Chief Scientific Officer | Sale | 50.0K | $56.81 | $2.8M | SEC ↗ |
| Jul 9, 2019 | James J Vaughn | Chief Commercial Officer | Sale | 4.5K | $57.09 | $256.9K | SEC ↗ |
| Jul 9, 2019 | Kim Mceachron | Chief People Officer | Sale | 5.3K | $60.01 | $320.2K | SEC ↗ |
| Jun 17, 2019 | Steven Shak | Chief Scientific Officer | Sale | 35.5K | $51.86 | $1.8M | SEC ↗ |
| Jun 13, 2019 | Steven Shak | Chief Scientific Officer | Sale | 50.0K | $51.38 | $2.6M | SEC ↗ |
Showing the 25 most recent of 132 Form 4 filings for GENOMIC HEALTH INC.
Most active GHDX insiders
- BAKER BROS. ADVISORS LP34 filings
- Steven Shak20 filings
- Kimberly J Popovits19 filings
- Bradley G Cole18 filings
- James J Vaughn16 filings
Ask anything about GHDX insider activity
Use Trabud's AI agent to query GENOMIC HEALTH INC's Form 4 history in plain English — "Show me GHDX CEO purchases this year" or compare it against any other ticker.
Open the AI agentGHDX insider trading FAQ
Are GENOMIC HEALTH INC insiders buying or selling?
GENOMIC HEALTH INC insiders reported no open-market purchases or sales in the last 12 months. Since January 2018, Trabud has recorded 132 Form 4 filings for GHDX: 1 buys ($0) and 131 sells ($456.8M). Over the full record that is net selling of $456.8M.
How many insiders trade GHDX stock?
13 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for GENOMIC HEALTH INC. The most recent filing was accepted on Nov 13, 2019.
Where does Trabud get GHDX insider trading data?
All GHDX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.